High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.
Options
BORIS DOI
Publisher DOI
PubMed ID
30890768
Date of Publication
2019-12
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Zander, Thilo | |
Betticher, Daniel | |
Egger, Thomas |
Series
Bone marrow transplantation
Publisher
Nature Publishing Group
ISSN
0268-3369
Access(Rights)
restricted